Downloads
Abstract
Acute rejection includes T cell - mediated rejection TCMR and antibody - mediated rejection (AMR). If TCMR is a result of a recipient T - cell mediated immune response targeting the donor allograft resulting in allograft injury of various severity with 20 - 40% after liver transplantation then antibody mediated rejection (AMR) is very rare complication of liver transplantation with a reported frequency of 0,3 - 2%, but can have very serious consequences such as early graft los or cirrhosis. Identifying and treatment AMR remain difficult due to the complexity of immunological and pathology diagnosis, lack of guidelines and long term monitoring. Treatment AMR after liver transplantation is often based on the experience of other centers and the kidney transplant team, including corticoid, plasma exchange, high dose of IVIG , may be combined with rituximab. In this case, we reported a case mixed transplant rejection between TCMR and AMR after liver transplant in a patient with biliary atresia - end stage liver disease with evidence of liver biosy and elevated anti HLA antiobodies (HLA PRA class I and II).
References
Lee BT, Fiel MI, Schiano TD, Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective. Journal of Hepatology, 2021;75(5):1203-1216.
Ronca V, Wootton G, Milani C, Cain O, The immunological basis of liver allograft rejection. Frontiers in immunology, 2020;11:2155.
Lee K-B, What Is Antibody-Mediated Rejection in Histologic Diagnosis in Liver Recipients? The Journal of the Korean Society for Transplantation, 2017;31(1):1-5.
Demetris AJ, Bellamy C, Gandhi C, Prost S, Nakanuma Y, Stolz D, Functional immune anatomy of the liver as an allograft. American journal of transplantation, 2016;16(6):1653-1680.
Robinson TJ, Hendele JB, Gimferrer I, Leca N, Biggins SW, Reyes JD, et al., Acute liver failure secondary to acute antibody mediated rejection after compatible liver transplant: A case report. World Journal of Hepatology, 2022;14(1):287.
Höroldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hübscher SG, et al., Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Liver transplantation, 2006;12(7):1144-1151.
Orandi BJ, Alachkar N, Kraus ES, Naqvi F, Lonze BE, Lees L, et al., Presentation and outcomes of C4d‐negative antibody‐mediated rejection after kidney transplantation. American Journal of Transplantation, 2016;16(1):213-220.
Zarrinpar A, Busuttil RW, Evading antigens ABO- incompatible liver transplantation. Nature Reviews Gastroenterology & Hepatology, 2015;12(12):676-678.
Demetris AJ, Zeevi A, O’Leary JG, ABO-compatible liver allograft antibody-mediated rejection: an update. Current opinion in organ transplantation, 2015;20(3):314.
Demetris AJ, Bellamy C, Hübscher S, O’leary J, Randhawa P, Feng S, et al., 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection. American Journal of Transplantation, 2016;16(10):2816-2835.
| Published | 05-12-2023 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 93 (2024) | |
| Section | Case report | |
| DOI | 10.38103/jcmhch.93.11 | |
| Keywords | Thải ghép qua trung gian kháng thể, thải ghép qua trung gian tế bào T Antibody - mediated rejection, T cell - mediated rejection |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Journal of Clinical Medicine Hue Central Hospital